Stem cell transplantation for primary immunodeficiency diseases
Authors:
- 1 December 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 14 (6) , 521-526
Abstract
Purpose of review This review describes recent studies on outcomes after allogeneic hematopoietic cell transplantation for primary immunodeficiency in North America, including severe combined immunodeficiency (SCID), Wiskott–Aldrich syndrome and chronic granulomatous disease. Recent findings Using uniform diagnostic criteria, the Primary Immune Deficiency Treatment Consortium described the baseline characteristics of newly diagnosed infants with SCID in North America. Analysis of outcomes of hematopoietic cell transplantation for SCID in North America from 2000 to 2009 showed that young infants, and older infants without active infection, had excellent survival irrespective of type of donor or transplant approach with regard to conditioning. Although pretransplant conditioning with chemotherapy had a clear and strong negative impact on survival in infants with active infection at the time of transplant, among survivors, conditioning was associated with improved immune reconstitution. However, the potential late effects of conditioning in these infants remain to be characterized. Advances in transplant outcomes for Wiskott–Aldrich syndrome and chronic granulomatous disease support the strategy of early transplantation before the onset of severe complications; additional multicenter studies are needed to fully define optimal approaches. Summary The formation of the Primary Immune Deficiency Treatment Consortium, a multiinstitutional North American consortium, has contributed to our understanding of outcomes after transplant for primary immunodeficiency.Keywords
This publication has 47 references indexed in Scilit:
- Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyBlood, 2011
- Chronic granulomatous disease: Overview and hematopoietic stem cell transplantationJournal of Allergy and Clinical Immunology, 2011
- Residual NADPH Oxidase and Survival in Chronic Granulomatous DiseaseNew England Journal of Medicine, 2010
- Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency Who Received Related Donor Bone Marrow Transplants without Pretransplant Chemotherapy or Post-transplant GVHD ProphylaxisThe Journal of Pediatrics, 2009
- Improving cellular therapy for primary immune deficiency diseases: Recognition, diagnosis, and managementJournal of Allergy and Clinical Immunology, 2009
- A DNA-PKcs mutation in a radiosensitive T–B– SCID patient inhibits Artemis activation and nonhomologous end-joiningJournal of Clinical Investigation, 2008
- Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: Current status and critical needsJournal of Allergy and Clinical Immunology, 2008
- Thymic Function after Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2000
- Complete Correction of the Wiskott-Aldrich Syndrome by Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1978
- Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated DonorNew England Journal of Medicine, 1977